Pulmonary Involvement in Patients with COVID-19 Pneumonia

This document discusses the potential long-term pulmonary effects of COVID-19, particularly focusing on whether lung damage observed in patients, such as bilateral pneumonia, will result in lasting sequelae like pulmonary fibrosis. The study draws parallels with the 2003 SARS-CoV outbreak, where a small percentage of recovered patients exhibited signs of pulmonary fibrosis. Given the phylogenetic similarity between SARS-CoV and COVID-19, the study aims to determine if COVID-19 will similarly lead to fibrotic lung sequelae and reduced lung function.